Senior Journalist - China Biotech
Dragonfly Therapeutics
This listing was originally posted on Dragonfly Therapeutics's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moEndpoints News is seeking a senior journalist who can help build our coverage of China’s booming biopharma industry. This is a role for a journalist who wants to set the agenda on one of biotech’s most important stories, and is interested in playing a crucial role expanding our coverage in the region.
In this role, you’ll cover Chinese biotechs including R&D work, public and private financial markets, and key industry power players. You’ll work closely with our team in the US to help readers understand how the US and China compete and cooperate. And you’ll help uncover cool startups, interesting science, and new entrepreneurs.
This is the first of several roles in the region that we hope to hire, as part of our growing coverage of China’s role in global biotech and how it serves its own citizens and interacts with the rest of the world.
The right candidate has a clearly articulated point of view on the biotech industry, experience reporting in China, is a strong writer or editor, and is ready and able to work with our colleagues in the US and UK as a team player. We plan to eventually hire more staff in the region, and we’re looking for somebody who can lead by example, and eventually help manage a team. You’ll have the opportunity to shape our coverage and our regional footprint, help hire additional resources in the region, and will have a high-impact, high-profile role at Endpoints.
🌍 Work From Anywhere!
👥 Positive, Supportive, and Collaborative Work Culture.
🌴 Enhanced Annual Leave.
🩺 Healthcare Scheme: Private medical insurance offered to you and your family (spouse/partner and children).
🦷 Dental Scheme and Eye Care.
💸 Pension Scheme
📁 Life Insurance.
👪 Global Paid Parental Leave: This includes 20 weeks maternity leave and 12 weeks paternity leave.
💪 Paid Volunteer Days: Provides employees with the opportunity to engage in community service & volunteer activities.
💻 Equipment Provided: Laptop, monitor, and additional equipment needs.
Endpoints News is an equal opportunity employer. We celebrate diverse backgrounds and thoughts and welcome everyone to apply for employment with us. We are committed to fostering an environment that is inclusive, transparent, and collaborative. Mutual respect is central to how Endpoints News operates, and we believe the best solutions come from diverse perspectives, experiences, and skills. We embrace our differences and know that we are stronger working together.
About Endpoints News Media Company, LLC
Endpoints News is a media company covering the most critical developments for leaders across the biopharma world. Launched in 2016, Endpoints News has become the way drug development executives stay informed. Reported by a global team of journalists — led by co-founder John Carroll & Executive Editor Drew Armstrong — Endpoints covers news as it happens and delivers an inimitable twice-daily email report to an engaged audience in the business of discovering, researching, marketing, and regulating biotech drugs. In April, 2023, the Financial Times took a controlling stake in Endpoints News.
The Financial Times is one of the world’s leading business news organizations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of 1.2 million, more than one million of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community.
We'll notify you when matching roles are posted.
Interviewed at Dragonfly Therapeutics?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Immuno-oncology Drugs
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access salary benchmarks and market rate data and other premium pharma intelligence.
Upgrade to Pro — $25/mo